Changing the course of osteoarthritis (OA) treatment…

*Receive our FREE Technical Bulletin for signing up!

NEW Synovetin OA breaks the cycle of inflammation and pain, clinically improving mobility and providing long-lasting relief.

Synovetin OA™ is a novel conversion electron therapeutic device that targets the source of inflammation and pain—macrophages and synoviocytes in the affected joint.1,2

Provides long-lasting pain and inflammation relief

Restores the active lives of dogs with their families

Alters the treatment of chronic OA

Find out how Synovetin OA™ treats the debilitating pain of OA and helps restore your patients’ ability to be playful, happy, life-loving pets.1,2

NEW Synovetin OA is from Exubrion Therapeutics

At Exubrion Therapeutics, we are harnessing the power of conversion electron therapy from Tin-117m in a colloid suspension. We’re making a quantum leap forward in pain management thanks to a team of experts with decades of experience in animal health and nuclear medicine and a shared vision to forever improve the compassionate care of companion animals.

References:

1) Fox SM, Donecker JM. Synovitis. Technical Bulletin. Convetra, Inc. July 2016.

2) Data on File, Exubrion Therapeutics.

Receive our FREE Clinical Trial Technical Bulletin when you sign up for updates.
Receive our FREE Clinical Trial Technical Bulletin when you sign up for updates.

Synovetin OA is marketed by:

© 2019 Exubrion Therapeutics, Inc.
All rights reserved.
info@exubrion.com

Sign Up For Updates

Thank you for signing up. We'll email you our Technical Bulletin shortly, and be on the look out for new information in the coming weeks.

Sign Up a Webinar or Updates

Thank you for signing up. We'll email you our Technical Bulletin shortly, and be on the look out for new information in the coming weeks.